Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Plandai Biotechnology Inc (OP: PLPL )

0.0002 +0.0001 (+100.00%)
Streaming Delayed Price Updated: 11:35 AM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Plandai Biotechnology Inc

Plandai Biotechnology, Inc. Announces Rescission of Material Definitive Agreement with Good Salt, LLC
Via ACCESSWIRE
Third-Party Valuation Firm Provides Estimated Valuation of ByoPlanet's (A Subsidiary Of Plandai – $PLPL) Business and Assets
Via ACCESSWIRE
Byoplanet Unveils Bold Roadmap for the Upcoming Year, Under the Leadership of CEO Rick O'Shea
Via ACCESSWIRE
ByoPlanet's bCOOL(TM) Cooling Technology Enhances Performance and Recovery for Major League and College Teams
Via ACCESSWIRE
ByoPlanet and Merck Animal Health Announce Partnership with USEF
Via ACCESSWIRE
Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health
Via ACCESSWIRE
Following Completed Share Exchange Agreement with ByoPlanet, Plandai Announces Material Rebranding to Disinfectant Industry Focus
Via ACCESSWIRE
ByoPlanet Announces Completion of Share Exchange Agreement with Plandai Biotechnology
Via ACCESSWIRE
Plandai Biotechnology, Inc. Announces Entry into Material Share Exchange Agreement with Good Salt, LLC
Via ACCESSWIRE
Plandai Biotechnologies, Inc. Announces Termination of Asset Acquisition Agreement with EV Hotel, Updates on Status of Independent Audit
Via ACCESSWIRE
EV Hotel Corp. and Plandai Biotechnologies Enter Into Asset Acquisition Agreement to Create the Leading Smart Hotel Brand - EV Hotel Corp.
Via ACCESSWIRE
Plandai Biotechnologies, Inc. Announces Entry into Non-Binding Letter of Intent, Updates on Status of Independent Audit
Via ACCESSWIRE
Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent
Via ACCESSWIRE
Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent
SAN DIEGO, CA / ACCESSWIRE / July 27, 2022 / Plandai Biotechnology, Inc. ("Plandai" or the "Company") announces the termination of its non-binding letter of intent dated May 23, 2022, with Ms. Jessie... 
From Plandai Biotechnology
Via AccessWire
SEC Cancels Regulatory Penalty and Interest Concerning Legacy Civil Enforcement Action
SAN DIEGO, CA / ACCESSWIRE / June 22, 2022 / Plandai Biotechnology Inc. (OTC PINK:PLPL) (the "Company") today announced that the U.S. Securities and Exchange Commission canceled civil penalties and... 
From Plandai Biotechnology
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Plandai Biotechnology In Non-Binding Letter of Intent to Acquire Rights to Puriblood’s Leukocyte Reduction Blood Filtration System with Plans to Address the International Blood Filtration Market
SAN DIEGO, CA / ACCESSWIRE / May 23, 2022 / Plandai Biotechnology Inc. (OTC PINK:PLPL) (the "Company") today announced its entry into a non-binding letter of intent to enter into a new business through... 
From Plandai Biotechnology
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.